Palantir's stock dropped 5% on November 3rd, despite U.S. commercial revenue ($984M) surpassing government revenue ($953M) for the first time. Investors are watching U.S. commercial TCV growth, which slowed to 11% in Q3 from 153% previously. Goldman Sachs previously projected an 18% upside on sovereign AI.